NewEdge Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
NewEdge Wealth's IBB Position: Q1 2026 in Review
NewEdge Wealth increased its iShares Biotechnology ETF (IBB) stake by 0.59% in Q1 2026, buying an estimated $9.4K and bringing the position to 9,391 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #493.
NewEdge Wealth first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- NewEdge Wealth held 9,391 shares of iShares Biotechnology ETF worth $1.59M as of Q1 2026.
- NewEdge Wealth bought 55 iShares Biotechnology ETF shares in Q1 2026, an estimated $9.4K.
- iShares Biotechnology ETF made up 0.02% of NewEdge Wealth's portfolio in Q1 2026, its #493 holding.
- NewEdge Wealth first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.